Target organ damage in patients with rheumatoid arthritis: The role of blood pressure and heart rate

Dzau, 2006, The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Part I. Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease), Circulation, 114, 2850, 10.1161/CIRCULATIONAHA.106.655688 Agabiti-Rosei, 1998, Cardiac hypertrophy and hypertension, Curr Opin Nephrol Hypertens, 7, 211, 10.1097/00041552-199803000-00011 Pedrinelli, 2002, Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension, J Hum Hypertens, 16, 79, 10.1038/sj.jhh.1001316 Hillege, 2001, Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity, J Intern Med, 249, 519, 10.1046/j.1365-2796.2001.00833.x Cohuet, 2006, Mechanisms of target organ damage caused by hypertension: therapeutic potential, Pharmacol Ther, 111, 81, 10.1016/j.pharmthera.2005.09.002 Adler, 2002, Obesity and target organ damage: diabetes, Int J Obes Relat Metab Disord, 26, S11, 10.1038/sj.ijo.0802212 Leoncini, 2005, Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients, J Intern Med, 257, 454, 10.1111/j.1365-2796.2005.01468.x Viazzi, 2002, Pulse pressure and subclinical cardiovascular damage in primary hypertension, Nephrol Dial Transplant, 17, 1779, 10.1093/ndt/17.10.1779 Viazzi, 2005, Serum uric acid and target organ damage in primary hypertension, Hypertension, 45, 991, 10.1161/01.HYP.0000161184.10873.ea Palatini, 1997, Heart rate and the cardiovascular risk, J Hypertens, 15, 3, 10.1097/00004872-199715010-00001 Marinakis, 2003, Heart rate and blood pressure variability are predictors of target organ damage in arterial hypertension, Am J Hypertension, 16, 246A, 10.1016/S0895-7061(03)00747-7 Navarro-Gonzalez, 2008, Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension, J Hypertens, 26, 2168, 10.1097/HJH.0b013e32830e2545 Symmons, 2002, The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century, Rheumatology, 41, 793, 10.1093/rheumatology/41.7.793 Maki-Petaja, 2006, Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy, Circulation, 114, 1185, 10.1161/CIRCULATIONAHA.105.601641 Gonzalez-Juanatey, 2003, Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease, Medicine (Baltimore), 82, 407, 10.1097/01.md.0000101572.76273.60 Panoulas, 2008, Hypertension in rheumatoid arthritis, Rheumatology (Oxford), 47, 1286, 10.1093/rheumatology/ken159 Panoulas, 2007, Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis, Rheumatology (Oxford), 46, 1477, 10.1093/rheumatology/kem169 Libby, 2008, Role of inflammation in atherosclerosis associated with rheumatoid arthritis, Am J Med, 121, S21, 10.1016/j.amjmed.2008.06.014 Dekkers, 2004, Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease, Clin Exp Rheumatol, 22, 63 Panoulas, 2007, Association of serum uric acid with cardiovascular disease in rheumatoid arthritis, Rheumatology (Oxford), 46, 1466, 10.1093/rheumatology/kem159 Mancia, 2007, 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension, J Hypertens, 25, 1751, 10.1097/HJH.0b013e3282f0580f Williams, 2004, Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV, J Hum Hypertens, 18, 139, 10.1038/sj.jhh.1001683 National Collaborating Centre for Chronic Conditions, 2006 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Katz, 2000, Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans, J Clin Endocrinol Metab, 85, 2402, 10.1210/jcem.85.7.6661 Molloy, 1992, Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product, J Am Coll Cardiol, 20, 1180, 10.1016/0735-1097(92)90376-X Okin, 1995, Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products, J Am Coll Cardiol, 25, 417, 10.1016/0735-1097(94)00371-V Sokolow, 1949, The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads, Am Heart J, 37, 161, 10.1016/0002-8703(49)90562-1 Cea-Calvo, 2006, Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study, Cardiovasc Diabetol, 5, 23, 10.1186/1475-2840-5-23 van Halm, 2008, Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross-sectional study. The CARRE Investigation, Ann Rheum Dis Cuspidi, 2000, Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control, J Hypertens, 18, 803, 10.1097/00004872-200018060-00020 Pannier, 1989, Pulse pressure and echocardiographic findings in essential hypertension, J Hypertens, 7, 127, 10.1097/00004872-198902000-00008 Cirillo, 2000, Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group, Kidney Int, 58, 1211, 10.1046/j.1523-1755.2000.00276.x Cuspidi, 2001, High prevalence of cardiac and extracardiac target organ damage in refractory hypertension, J Hypertens, 19, 2063, 10.1097/00004872-200111000-00018 Stevens, 2005, Inflammation and atherosclerosis in rheumatoid arthritis, Expert Rev Mol Med, 7, 1, 10.1017/S1462399405009154 Panoulas, 2008, Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis, Rheumatology (Oxford), 47, 72, 10.1093/rheumatology/kem311 Toms, 2008, Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study, Arthritis Res Ther, 10, R145, 10.1186/ar2578 Mahmud, 2005, Arterial stiffness is related to systemic inflammation in essential hypertension, Hypertension, 46, 1118, 10.1161/01.HYP.0000185463.27209.b0 Capellino, 2008, Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus, J Rheumatol, 35, 91 Gordon, 1981, Intimal alterations in rat aorta induced by stressful stimuli, Lab Invest, 45, 14 Kaplan, 1987, Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet, Circulation, 76, 1364, 10.1161/01.CIR.76.6.1364 Laks, 1973, Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog, Chest, 64, 75, 10.1378/chest.64.1.75 Hartford, 1983, Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors, Clin Exp Hypertens A, 5, 1429 Bevan, 1983, Cerebral artery mass in the rabbit is reduced by chronic sympathetic denervation, Stroke, 14, 393, 10.1161/01.STR.14.3.393 Julius, 1975, Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension, Circ Res, 36, 199, 10.1161/01.RES.36.6.199 Douglas, 2006, Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome, Ann Rheum Dis, 65, 348, 10.1136/ard.2005.037978 Panoulas, 2008, Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis, J Hum Hypertens, 22, 177, 10.1038/sj.jhh.1002298 Daoussis, 2009, Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis, Ann Rheum Dis Sundstrom, 2001, Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men, Circulation, 103, 2346, 10.1161/01.CIR.103.19.2346 Barrabes, 2009, Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction, Am J Cardiol, 103, 455, 10.1016/j.amjcard.2008.10.006